Connect With a Global Community of 65+ Dermatology Experts

With pipelines advancing into Phase II–IV, sponsors face growing pressure around trial feasibility, placebo and vehicle effects, fragmented European recruitment, regulatory scrutiny, and delivery and manufacturing readiness for advanced modalities. As a result, pharma and biotech teams are reassessing how, and with whom, they partner to de-risk development and accelerate execution. 

The 7th Dermatology Drug Development Europe Summit has been built directly from live research calls with senior R&D, medical and regulatory leaders to address these challenges head-on. This creates a rare opportunity for solution providers to engage an invitation-driven audience of 65+ decision-makers actively planning dermatology programmes and seeking external expertise across biomarkers, imaging, clinical and preclinical trials, formulation and manufacturing. 

4

What to Expect?

Connect with Active Dermatology Program Leaders

Build relationships with senior pharma and biotech decision-makers who are actively planning or executing dermatology programmes and seeking partners to address feasibility, recruitment, formulation, biomarker and late-stage clinical challenges.

Position Your Brand at the Centre of Strategic Partnering

Gain high-visibility exposure to C-suite, clinical and regulatory leaders through curated branding across the summit website, agenda, and on-site touchpoints within a focused, senior audience.

Demonstrate Relevant, In-Context Expertise

Showcase your capabilities through speaking opportunities, panel participation, workshops or targeted exhibition placementspositioning your solutions directly within discussions on real dermatology development barriers, rather than generic service pitches.

Access Real-World Market Intelligence

Hear unfiltered insights from dermatology leaders sharing current trial failures, regulatory shifts, access constraints and pipeline strategiesequipping you with actionable intelligence to refine offerings and strengthen competitive positioning. 

Key Interest Areas [Option 2]

Our attendees from Glenmark Pharmaceuticals, Noa Therapeutics, Nektar Therapeutics, Sanofi and more are looking for service and solution providers with capabilities in the below areas but not limited to: 

Biomarkers 

Imaging 

Clinical CROs  

Preclinical CROs  

CDMOs 

Formulation 

Hear What Our Past Sponsors Have to Say

SymBio Logo

Great presentations, excellent roundtable discussions, and enjoyable panel discussions. Really great, focused conference!

David Bruce, Business Development Consultant, Symbio

Precefi Logo

You had all the right people in attendance.

Richard Panico, Chief Executive Officer, Precefi 

12

It's a focused meeting. It's short and to the point. The speed networking the first morning really breaks the ice.

Colin Davies, Business Development Manager, Contract Pharmaceuticals Limited 

Attending Companies Include

Available Inventory

We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.

Presenting Slots Images
Leading Innovation Image
Full Delegate List Image
Exhibiting Image
Networking Image
Bespoke Hosting Image
Champion the Industry Image
Branding Image

Get in Touch

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Name Surname

Job Title
Event/ Topic Area Name

3
Stay Front-of-Mind in Dermatology Drug Development

Position your brand at the centre of late-stage dermatology R&D discussions where pharma and biotech leaders are actively evaluating partners. 

3
Connect with Buyers, Not Browsers

Meet senior clinical and development decision-makers in a focused, invitation-only environment designed for real partnership conversations. 

13
Activate Your Value Proposition

Showcase your capabilities through tailored sponsorship, speaking and branding opportunities aligned to active dermatology pipeline needs.